SEARCH

SEARCH BY CITATION

References

  • Amaral L, Viveiros M & Kristiansen JE (2001) Phenothiazines: potential alternatives for the management of antibiotic resistant infections of tuberculosis and malaria in developing countries. Tropical Medicine and International Health 6, 10161022.
  • Beutler E & Mitchell M (1968) Special modifications of the fluorescent screening method for glucose-6-phosphate dehydrogenase deficiency. Blood 32, 816818.
  • Bloland PB, Ettling M & Meek S (2000) Combination therapy for malaria in Africa: hype or hope? Bulletin of the World Health Organisation 78, 13781388.
  • Brewer GJ, Tarlov AR & Alving AS (1962) The methemoglobin reduction test for primaquine-type sensitivity of erythrocytes. A simplified procedure for detecting a specific hypersusceptibility for drug hemolysis. JAMA 180, 386388.
  • Coulibaly B (2004) Malaria-related studies on enzymopathies, methemoglobin, and methylene blue. PhD Thesis, Heidelberg University, Germany.
  • CPMP (1997) Note for Guidance on Clinical Investigation of Medicinal Products in Children. CPMP/EWP/462/95 (Available at: http://www.emea.eu.int/pdfs/human/ewp/046295en.pdf).
  • Dorsey G, Njama D, Kamya MR et al. (2002) Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial. The Lancet 360, 20312038.
  • Ehrlich P (1913) Chemotherapeutics: scientific principles, methods, and results. The Lancet ii, 445451.
  • Färber PM, Arscott LD, Williams CH, Becker K & Schirmer RH (1998) Recombinant Plasmodium falciparum glutathione reductase is inhibited by the antimalarial dye methylene blue. FEBS Letters 422, 311314.
  • Ferreira C (1893) Sur l'emploi du bleu de méthylène dans la malaria infantile. Revue de Thérapeutique Médico-Chirugicale 1893, 488525.
  • Fleming AF & de Silva PS (2003) G6PD deficiency. In: Manson's Tropical Diseases (eds GCCook & AZumla) Elsevier Science Ltd, Edinburgh, pp. 208212.
  • Gasasira AF, Dorsey G, Nzarubara B et al. (2003) Comparative efficacy of amodiaquine-antifolate combinations for the treatment of uncomplicated falciparum malaria in Kampala, Uganda. American Journal of Tropical Medicine and Hygiene 68, 127132.
  • Goluboff N & Wheaton R (1961) Methylene blue induced cyanosis and acute haemolytic anemia complicating the treatment of methemoglobinaemia. Journal of Pediatrics 58, 8689.
  • Greenwood B & Mutabingwa T. (2002) Malaria in 2002. Nature 415, 670672.
  • Greenwood B, Bradley A, Greenwood A et al. (1987) Mortality and morbidity from malaria among children in a rural area of The Gambia. Transactions of the Royal Society of Tropical Medicine and Hygiene 81, 478486.
  • Guttmann P & Ehrlich P (1891) Über die Wirkung des Methylenblau bei Malaria. Berliner Klinische Wochenschrift 28, 953956.
  • International Artemisinin Study Group (2004) Artesunate combinations for treatment of malaria: meta-analysis. The Lancet 363, 917.
  • Lang T & Greenwood B (2003) The development of Lapdap, an affordable new treatment for malaria. The Lancet Infectious Diseases 3, 162168.
  • Meierjohann S, Walter RD & Müller S (2002) Regulation of intracellular glutathione levels in erythrocytes infected with chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum. Biochemical Journal 368, 761768.
  • Müller O, Becher H, Baltussen A et al. (2001) Effect of zinc supplementation on malaria and other causes of morbidity in west African children: randomized double blind placebo controlled trial. British Medical Journal 322, 15671572.
  • Müller O, Traoré C, Kouyaté B & Becher H (2003a) Malaria morbidity, treatment seeking behaviour, and mortality in a cohort of young children in rural Burkina Faso. Tropical Medicine and International Health 8, 290296.
  • Müller O, Traoré C & Kouyaté B (2003b) Clinical efficacy of chloroquine in young children with uncomplicated malaria – a community based study in rural Burkina Faso. Tropical Medicine and International Health 8, 202203.
  • Nosten F & Brasseur P (2002) Combination therapy for malaria. Drugs 62, 13151329.
  • Ruwende C & Hill A (1998) Glucose-6-phosphate dehydrogenase deficiency and malaria. Journal of Molecular Medicine 76, 581588.
  • Rwangacondo C, Niyitegeka F, Sarushi J et al. (2003) Efficacy of amodiaquine alone and combined with sulfadoxine-pyrimethamine and of sulfadoxine pyrimethamine combined with artesunate. American Journal of Tropical Medicine and Hygiene 68, 743747.
  • Scheiwein M (2001) Pathophysiologische und chemotherapeutische Mechanismen der Glutathionreduktase-Inaktivierung bei Malaria. MD thesis, Heidelberg University, Germany.
  • Schirmer RH, Coulibaly B, Stich A et al. (2003) Methylene blue as an antimalarial agent. Redox Report 8, 272276.
  • Simon R (1989) Optimal two-stage designs for phase II clinical trials. Controlled Clinical Trials 10, 110.
  • Snow RW, Craig M, Deichmann U & Marsh K (1999) Estimating mortality, morbidity and disability due to malaria among Africa's non-pregnant population. Bulletin of the World Health Organisation 77, 624640.
  • Trape J (2001) The public health impact of chloroquine resistance in Africa. American Journal of Tropical Medicine and Hygiene 64 (Suppl.), 1217.
  • Vennerstrom JL, Makler MT, Angerhofer CK & Williams JA (1995) Antimalarial dyes revisited: xanthenes, azines, oxazines, and thiazines. Antimicrobial Agents and Chemotherapy 39, 26712677.
  • White NJ, Nosten F, Looareesuwan S et al. (1999) Averting a malaria disaster. The Lancet 353, 19651967.
  • WHO (1997) World malaria situation in 1994. Weekly Epidemiological Record 72, 269292.
  • Winstanley P (2001) Modern chemotherapeutic options for malaria. The Lancet Infectious Diseases 1, 242250.